Frélii, Inc.

FRLI

US3570511010

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 15:51:33 2024-05-14 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2020	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
2020	Frélii, Inc. announced that it has received $0.203 million in funding	CI

Frélii, Inc. announced that it has received $0.125 million in funding from Current Capital Corp.

July 19, 2018

On July 20, 2018, Frélii, Inc. (OTCPK:FRLI) closed the transaction.

Latest news about Frélii, Inc.

Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	20-12-16	CI
Frélii, Inc. announced that it has received $0.203 million in funding	20-01-08	CI
Frélii, Inc. entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. for $0.94 million from Helix Investment Partners LLC.	19-12-22	CI
Frélii, Inc. announced that it has received $0.154 million in funding	19-11-14	CI
Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
Frelii, Inc. Announces Resignation of Leslie Norris as Chief Operating Officer; Opens Its First Wholly Owned Subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada	19-07-16	CI
Frélii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment	19-06-10	CI
Frelii Inc. Announces Executive Changes	19-05-22	CI
Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-20	CI
Frélii, Inc. Signs Contract and Licensing Agreement with Optivida Health	19-05-01	CI
Frélii, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-16	CI
Frélii, Inc. Announces Address Change	19-04-12	CI
NewPath Health Care Solutions, Inc Frélii, Inc. Mercator Biologic, Inc. and True DNA Story, LLC Enter into Memorandum of Understanding to Strategically Explore the Full Capabilities of Each Company	19-03-21	CI
Frelii Inc. Signs Memorandum of Understanding with NewPath Health Care Solutions, Inc., Mercator Biologic, Inc. and True DNA Story, LLC	19-03-20	CI
Frelii Inc. Appoints Two New Members to Its Scientific Advisory Board	19-02-14	CI
Frelii Inc. Announces Appointment of Leslie M. Norris to its Board of Directors	18-12-20	CI
Frelii Enters into Licensing Agreement with Newpath Healthcare	18-12-10	CI
Frélii, Inc. announced that it has received $0.125 million in funding from Current Capital Corp.	18-07-19	CI
Frélii, Inc. Announces Resignation of Julia Kline as Chief Operating Officer and Corporate Secretary	18-07-16	CI
Frélii, Inc. announced that it expects to receive $0.125 million in funding from Current Capital Corp.	18-06-19	CI
Frélii, Inc. Announces Management Changes	18-03-28	CI
Vican Resources, Inc. will Change its Name to Frélii, Inc	18-03-09	CI
Frélii, Inc. will Change its Ticker to FRLI from VCAN	18-03-09	CI
Unprescribed, LLC cancelled the acquisition of Vican Resources, Inc in a reverse merger transaction.	17-12-30	CI

Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Software & Technology Services

	1st Jan change	Capi.
FRÉLII, INC.	0.00%	58
VEEVA SYSTEMS INC.	+5.91%	32.95B
PRO MEDICUS LIMITED	+20.73%	8.01B
SECTRA AB	+34.25%	4.38B
EVOLENT HEALTH, INC.	-29.52%	2.67B
OMNICELL, INC.	-13.29%	1.5B
VERADIGM INC.	-28.02%	1.27B
LUNIT INC.	-30.53%	1.2B
SIMULATIONS PLUS, INC.	+11.35%	996M
B-SOFT CO.,LTD.	-38.17%	864M

Medical Software & Technology Services

Frélii, Inc.

Equities

FRLI

US3570511010

Advanced Medical Equipment & Technology

Frélii, Inc. announced that it has received $0.125 million in funding from Current Capital Corp.

Latest news about Frélii, Inc.

Chart Frélii, Inc.

Company Profile

Sector Medical Software & Technology Services